MYZQF (Advanced Health Intelligence) Operating Income : $0.00 Mil (TTM As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Advanced Health Intelligence Operating Income?

Advanced Health Intelligence's Operating Income for the three months ended in Mar. 2024 was $0.00 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2024 was $0.00 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. Advanced Health Intelligence's Operating Income for the three months ended in Mar. 2024 was $0.00 Mil. Advanced Health Intelligence's Revenue for the three months ended in Mar. 2024 was $0.00 Mil. Therefore, Advanced Health Intelligence's Operating Margin % for the quarter that ended in Mar. 2024 was %.

Good Sign:

Advanced Health Intelligence Ltd operating margin is expanding. Margin expansion is usually a good sign.

Advanced Health Intelligence's 5-Year average Growth Rate for Operating Margin % was 17.10% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Advanced Health Intelligence's annualized ROC % for the quarter that ended in Mar. 2024 was 0.00%. Advanced Health Intelligence's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 0.00%.

Advanced Health Intelligence Operating Income Historical Data

The historical data trend for Advanced Health Intelligence's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced Health Intelligence Operating Income Chart

Advanced Health Intelligence Annual Data

Trend

Apr15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Operating Income

Get a 7-Day Free Trial

-4.45

-9.58

-13.08

-6.95

Advanced Health Intelligence Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Operating Income	Get a 7-Day Free Trial															-	-	-	-	-

Advanced Health Intelligence Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Advanced Health Intelligence (OTCPK:MYZQF) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Advanced Health Intelligence's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

	ROC % (Q: Mar. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2023 )	+	Invested Capital (Q: Mar. 2024 ))	/ count )
=	0 * ( 1 - % )	/	( (5.795	+	0)	/ 1 )
=	0	/	5.795
=	0.00 %

where

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	4.764	-	3.4	-	( 0.309	-	max(0, 5.539	-	1.108	+	0.309	))
=	5.795

	Invested Capital		(Q: Mar. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	0	-	0	-	( 0	-	max(0, 0	-	0	+	0	))
=	0

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Advanced Health Intelligence's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2023		Q: Mar. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	0	/	( ( (0.292 + max(-3.756, 0))	+	(0 + max(0, 0)) )	/	1 )
=	0	/	( ( 0.292	+	0 )	/	1 )
=	0	/	0.292
=	0.00 %

where Working Capital is:

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.094	+	0	+	0.528)	-	(3.4	+	0.39	+	0.588)
=	-3.756

	Working Capital		(Q: Mar. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	0)	-	(0	+	0	+	0)
=	0

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. Operating Income is also linked to Operating Margin %:

Advanced Health Intelligence's Operating Margin % for the quarter that ended in Mar. 2024 is calculated as:

Operating Margin %	=	Operating Income (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	0	/	0
	=	%

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.

Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.

Advanced Health Intelligence Operating Income Related Terms

Thank you for viewing the detailed overview of Advanced Health Intelligence's Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Advanced Health Intelligence Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Software » Advanced Health Intelligence Ltd (OTCPK:MYZQF) » Definitions » Operating Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

71-73 The Esplanade, Unit 5, South Perth, Perth, WA, AUS, 6151

Website

https://www.ahi.tech

Advanced Health Intelligence Ltd (AHI) is engaged in developing and delivering user-friendly biometric scans to render vital signs and health risk estimates to a smartphone. By leveraging the smartphone with purpose-built computer vision, machine learning models, and patented algorithms, AHI provides a private and secure way for individuals to perform biometric health-risk assessment and stratification. AHI's technology delivers simple-to-use, scalable, and cost-effective means to enable individuals to check, track and act towards better health outcomes. The combination of the patented and proprietary BodyScan dimensioning and composition capabilities and, FaceScan to return vital signs enables a unique health assessment capability made accessible anytime, anywhere through the smartphone.